↓ Skip to main content

PLOS

Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses

Overview of attention for article published in PLOS ONE, May 2014
Altmetric Badge

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
36 Mendeley
Title
Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses
Published in
PLOS ONE, May 2014
DOI 10.1371/journal.pone.0094883
Pubmed ID
Authors

Catherine Gérard, Nathalie Baudson, Thierry Ory, Jamila Louahed

Abstract

MAGE-A3 is a potential target for immunotherapy due to its tumor-specific nature and expression in several tumor types. Clinical data on MAGE-A3 immunotherapy have raised many questions that can only be addressed by using animal models. In the present study, different aspects of the murine anti-tumor immune responses induced by a recombinant MAGE-A3 protein (recMAGE-A3) in combination with different immunostimulants (AS01, AS02, CpG7909 or AS15) were investigated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 22%
Student > Bachelor 5 14%
Researcher 5 14%
Other 2 6%
Student > Master 2 6%
Other 4 11%
Unknown 10 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 17%
Medicine and Dentistry 5 14%
Immunology and Microbiology 4 11%
Agricultural and Biological Sciences 3 8%
Chemistry 2 6%
Other 6 17%
Unknown 10 28%